National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 52408 [05-17515]

Download as PDF 52408 Federal Register / Vol. 70, No. 170 / Friday, September 2, 2005 / Notices This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: August 26, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–17463 Filed 9–1–05; 8:45 am] Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Sujata Vijh, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 594– 0985, vijhs@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.955, Allergy, Immunology and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 25, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–17515 Filed 9–1–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–M National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Review of an Unsolicited P01. Date: September 22, 2005. Time: 10 a.m. to 1 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Cheryl P. Lapham, PhD, Scientific Review Administrator, Scientific Review Program, National Institutes of Allergy and Infectious Diseases, DEA/NIH/ DHHS, 6700B Rockledge Drive, MSC 7616, Room 3127, Bethesda, MD 20892–7616, 301– 402–4598, clapham@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Minor H Antigens and Kidney Transplantation. Date: September 23, 2005. Time: 2 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, VerDate Aug<18>2005 18:00 Sep 01, 2005 Jkt 205001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of Refugee Resettlement Final Notice for FY 2005 Formula Allocation for Targeted Assistance Grants to States for Services to Refugees Office of Refugee Resettlement (ORR), ACF, HHS. ACTION: Final notice of availability of allocations for FY 2005 targeted assistance grants to States for services to refugees 1 in local areas of high need. AGENCY: [CFDA No. 93.584, Refugee and Entrant Assistance—Targeted Assistance Grants] SUMMARY: This final notice announces the availability of funds and award procedures for FY 2005 Targeted Assistance Program (TAP) grants to States for services to refugees under the Refugee Resettlement Program (RRP). These grants are for service provision in localities with large refugee populations, high refugee concentrations, and where specific needs exist for supplementation of currently available resources. 1 In addition to persons who meet all requirements of 45 CFR 400.43, ‘‘Requirements for documentation of refugee status,’’ eligibility for targeted assistance includes refugees, asylees, Cuban and Haitian entrants, certain Amerasians from Viet Nam who are admitted to the U.S. as immigrants, certain Amerasians from Viet Nam who are U.S. citizens and victims of a severe form of trafficking who receive certification or eligibility letters from ORR, and certain other specified family members of trafficking victims. See Section II of this notice on ‘‘Authorization,’’ and refer to 45 CFR 400.43 and the ORR State Letter #01–13 on the Trafficking Victims Protection Act dated May 3, 2001, as modified by ORR State Letter #02–01, January 4, 2002, and ORR State Letter #04–12, June 18, 2004. The term ‘‘refugee,’’ used in this notice for convenience, is intended to encompass such additional persons who are eligible to participate in refugee program services, including the targeted assistance program. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Qualification of counties for eligibility for targeted assistance program grants is determined once every three years as stated in the FY 1999 Notice of Proposed Availability of Targeted Assistance Allocations to States which was published in the Federal Register on March 10, 1999 (64 FR 11927). The FY 2002–FY 2004 three-year project cycle has expired. FY 2005 is the year for the re-qualification of counties for the three-year project cycle, FY 2005, FY 2006, and FY 2007 for TAP funds. Qualifications of counties are based on the arrivals of refugees (see Footnote 1, eligible population) during the 5-year period from FY 2000 through FY 2004, and on the concentration of the arrivals population as a percentage of the general population. Counties that qualify for TAP FY 2005 funds on the basis of the most current 5-year population are listed in this proposed notice in Table 1, Table 2, Table 4, and Table 6. Under this final notice, a total of 48 counties (Table 1) qualify for targeted assistance grants. Of these, 6 new counties (Table 2) qualify for targeted assistance grants, and 11 counties (Table 3) which previously received targeted assistance grants no longer qualify for targeted assistance program funding. Application Deadline: Application deadline for targeted assistance program funding will be September 12, 2005. A full application is required this qualifying year, FY 2005. Six (6) new counties are eligible for targeted assistance. Counties that have received TAP funds in the past and will continue to qualify for TAP have not been required to submit a full application since FY 2002. Application requirements in the second and third of a 3-year project cycle will be less extensive. FOR FURTHER INFORMATION CONTACT: Kathy Do, Division of Budget, Policy and Data Analysis (DBPDA), (202) 401– 4579; e-mail: kdo@acf.hhs.gov. SUPPLEMENTARY INFORMATION: I. Purpose and Scope This final notice announces the availability of Fiscal Year 2005 funds for targeted assistance grants for services to refugees (see Footnote 1 for eligible population) in counties where, because of factors such as unusually large refugee populations and high refugee concentrations, there exists and can be demonstrated a specific need for supplementation of resources for services to this population. The Office of Refugee Resettlement (ORR) has available $49,081,000 in FY 2005 funds for the targeted assistance E:\FR\FM\02SEN1.SGM 02SEN1

Agencies

[Federal Register Volume 70, Number 170 (Friday, September 2, 2005)]
[Notices]
[Page 52408]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-17515]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Review of an Unsolicited P01.
    Date: September 22, 2005.
    Time: 10 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Cheryl P. Lapham, PhD, Scientific Review 
Administrator, Scientific Review Program, National Institutes of 
Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700B Rockledge 
Drive, MSC 7616, Room 3127, Bethesda, MD 20892-7616, 301-402-4598, 
clapham@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Minor H Antigens and Kidney 
Transplantation.
    Date: September 23, 2005.
    Time: 2 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Sujata Vijh, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892, (301) 594-0985, vijhs@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.955, 
Allergy, Immunology and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 25, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-17515 Filed 9-1-05; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.